Related references
Note: Only part of the references are listed.Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome
Laurence Poekes et al.
CLINICAL SCIENCE (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
Siddharth Singh et al.
HEPATOLOGY (2015)
Moderate to Vigorous Physical Activity Volume Is an Important Factor for Managing Nonalcoholic Fatty Liver Disease: A Retrospective Study
Sechang Oh et al.
HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice
Fahrettin Haczeyni et al.
OBESITY (2015)
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
Stefano Fiorucci et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype
Geoffrey C. Farrell et al.
LIVER INTERNATIONAL (2014)
Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source
You-Ying Chau et al.
NATURE CELL BIOLOGY (2014)
Regulation of energy metabolism by long-chain fatty acids
Manabu T. Nakamura et al.
PROGRESS IN LIPID RESEARCH (2014)
Adipocyte dysfunction, inflammation and metabolic syndrome
Nora Kloeting et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo
Takahiro Horie et al.
SCIENTIFIC REPORTS (2014)
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Samuele De Minicis et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice
Deborah Heydet et al.
DEVELOPMENTAL NEUROBIOLOGY (2013)
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Elena Maneschi et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
Derrick M. Van Rooyen et al.
JOURNAL OF HEPATOLOGY (2013)
NAFLD in Asia-as common and important as in the West
Geoffrey C. Farrell et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Yongjie Ma et al.
PHARMACEUTICAL RESEARCH (2013)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease
Jayani Manchanayake et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
S. Fiorucci et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Hepatic FXR: key regulator of whole-body energy metabolism
Joao Soeiro Teodoro et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
Mouaadh Abdelkarim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
The Bile Acid Sensor Farnesoid X Receptor Is a Modulator of Liver Immunity in a Rodent Model of Acute Hepatitis
Andrea Mencarelli et al.
JOURNAL OF IMMUNOLOGY (2009)
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes
Claire Z. Larter et al.
JOURNAL OF HEPATOLOGY (2008)
The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2006)
Fat Aussie -: A new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis
Todor Arsov et al.
MOLECULAR ENDOCRINOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi et al.
HEPATOLOGY (2002)
Share Paper
